221 related articles for article (PubMed ID: 24718267)
1. A comparative study of experimental mouse models of central nervous system demyelination.
Dumitrascu OM; Mott KR; Ghiasi H
Gene Ther; 2014 Jun; 21(6):599-608. PubMed ID: 24718267
[TBL] [Abstract][Full Text] [Related]
2. Suppression of IL-12p70 formation by IL-2 or following macrophage depletion causes T-cell autoreactivity leading to CNS demyelination in HSV-1-infected mice.
Lee DH; Zandian M; Kuo J; Mott KR; Chen S; Arditi M; Ghiasi H
PLoS Pathog; 2017 May; 13(5):e1006401. PubMed ID: 28542613
[TBL] [Abstract][Full Text] [Related]
3. Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2.
Zandian M; Mott KR; Allen SJ; Dumitrascu O; Kuo JZ; Ghiasi H
Gene Ther; 2011 Jul; 18(7):734-42. PubMed ID: 21412284
[TBL] [Abstract][Full Text] [Related]
4. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
5. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
6. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
Furlan R; Bergami A; Brambilla E; Butti E; De Simoni MG; Campagnoli M; Marconi P; Comi G; Martino G
Gene Ther; 2007 Jan; 14(1):93-8. PubMed ID: 16929354
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of IL-17 Serum Level, Brain Inflammation and Demyelination in Experimental Autoimmune Encephalomyelitis C57BL/6 Mice Model with Different Doses of Myelin Oligodendrocyte Glycoprotein.
Ghorbani MM; Farazmandfar T; Nasirikenari M; Abediankenari S; Meamarian A; Shahbazi M
Iran J Allergy Asthma Immunol; 2019 Jun; 18(3):300-309. PubMed ID: 31522437
[TBL] [Abstract][Full Text] [Related]
8. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.
Bernard CC; Johns TG; Slavin A; Ichikawa M; Ewing C; Liu J; Bettadapura J
J Mol Med (Berl); 1997 Feb; 75(2):77-88. PubMed ID: 9083925
[TBL] [Abstract][Full Text] [Related]
9. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
[TBL] [Abstract][Full Text] [Related]
10. IL-2 suppression of IL-12p70 by a recombinant HSV-1 expressing IL-2 induces T-cell auto-reactivity and CNS demyelination.
Zandian M; Mott KR; Allen SJ; Chen S; Arditi M; Ghiasi H
PLoS One; 2011 Feb; 6(2):e16820. PubMed ID: 21364747
[TBL] [Abstract][Full Text] [Related]
11. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
Kerlero de Rosbo N; Mendel I; Ben-Nun A
Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
[TBL] [Abstract][Full Text] [Related]
12. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice.
Mokhtarian F; Zhang Z; Shi Y; Gonzales E; Sobel RA
J Neuroimmunol; 1999 Mar; 95(1-2):43-54. PubMed ID: 10229114
[TBL] [Abstract][Full Text] [Related]
13. Role of interleukin-2 and herpes simplex virus 1 in central nervous system demyelination in mice.
Mott KR; Zandian M; Allen SJ; Ghiasi H
J Virol; 2013 Nov; 87(22):12102-9. PubMed ID: 23986600
[TBL] [Abstract][Full Text] [Related]
14. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
[TBL] [Abstract][Full Text] [Related]
15. Optic neuritis in different strains of mice by a recombinant HSV-1 expressing murine interleukin-2.
Zandian M; Belisle R; Mott KR; Nusinowitz S; Hofman FM; Ghiasi H
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3275-82. PubMed ID: 19234357
[TBL] [Abstract][Full Text] [Related]
16. The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease.
Ben-Nun A; Mendel I; Bakimer R; Fridkis-Hareli M; Teitelbaum D; Arnon R; Sela M; Kerlero de Rosbo N
J Neurol; 1996 Apr; 243(4 Suppl 1):S14-22. PubMed ID: 8965116
[TBL] [Abstract][Full Text] [Related]
17. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Lee DH; Linker RA
Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
[TBL] [Abstract][Full Text] [Related]
18. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
19. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination.
Furlan R; Poliani PL; Galbiati F; Bergami A; Grimaldi LM; Comi G; Adorini L; Martino G
Hum Gene Ther; 1998 Nov; 9(17):2605-17. PubMed ID: 9853527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
